Neuroleptic and Huntington disease. Comparison of olanzapine, tetrabenazine and tiapride. A multicentric, randomised, controlled study.

Trial Profile

Neuroleptic and Huntington disease. Comparison of olanzapine, tetrabenazine and tiapride. A multicentric, randomised, controlled study.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 05 Jul 2017

At a glance

  • Drugs Olanzapine (Primary) ; Tetrabenazine (Primary) ; Tiapride (Primary)
  • Indications Huntington's disease
  • Focus Therapeutic Use
  • Acronyms NEUROHD
  • Most Recent Events

    • 30 Jul 2015 Planned primary completion date changed from 1 Mar 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov.
    • 30 Jul 2015 Planned end date changed from 1 Mar 2016 to 1 Mar 2017 as reported by ClinicalTrials.gov.
    • 01 Aug 2013 Planned end date changed from 1 Mar 2013 to 1 Sep 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top